Navigation Links
Cellular Dynamics International's (CDI) Human Induced Pluripotent Stem Cell (iPSC) Technology Named the Gold Winner in The Wall Street Journal 2011 Technology Innovation Awards
Date:10/17/2011

MADISON, Wis., Oct. 17, 2011 /PRNewswire/ -- Cellular Dynamics International (CDI) today announced that it was named as the overall Gold winner in The Wall Street Journal Technology Innovation Awards.

The Wall Street Journal 2011 Technology Innovation Awards are determined by a panel of independent judges who evaluated significant innovations that occurred in 2010.  Six-hundred-five applicants competed for the award in 16 categories.  Of these, the panel chose 35 winners and runners-up.

"Medical research has been challenged by the lack of access to a consistent supply of human cells, such as heart or brain cells," said Dr. James Thomson, CDI founder and chief scientific officer.  "Research today employs proxies, such as animal cells, tumor cell lines or cadaveric tissue, none of which truly reflect human biology.  I founded CDI based on my desire to make pluripotent stem cells and human tissue cells widely available to accelerate discoveries in human health and biological research. CDI's production technology and capacity provide this access, enabling us to manufacture human material from anyone. CDI has overcome the scalability challenges, mass producing industrial quantities of human cells in high quality and purity."

CDI has developed a proprietary manufacturing process in which cells isolated from a doctor's office standard blood draw from virtually anyone can be reprogrammed into that individual's personal pluripotent stem cell line.  CDI can then differentiate these stem cells into any cell type in the human body in industrial quantity, quality and purity so that scientists have a consistent supply of human cells from specific individuals.  Two human cell products, iCell® Cardiomyocytes (heart muscle cells) and iCell Endothelial Cells (blood vessel cells), have been launched over the past two years, with neurons and liver cells already available in early access collaborations with researchers worldwide.

"CDI is the first company to utilize stem cell technology to manufacture the vast quantities of high quality stem cells and tissue cells required to better understand human biology, revolutionize the drug discovery process, and develop cell-based therapies to treat human diseases," said Robert Palay, chairman of the board and CDI chief executive officer.  "We are honored that The Wall Street Journal's panel of independent judges recognized our company as a breakthrough innovator in human medicine and biotechnology."

About Cellular Dynamics International, Inc.

Cellular Dynamics International, Inc. (CDI) is a leading developer of next-generation stem cell technologies for drug development, cell therapy, tissue engineering and organ regeneration.  CDI harnesses its unique manufacturing technology to produce differentiated tissue cells from any individual's stem cell line in industrial quality, quantity and purity. CDI is accelerating the adoption of pluripotent stem cell technology, adapting its methods to fit into standard clinical practice by the creation of individual stem cell lines from a standard blood draw.  CDI was founded in 2004 by Dr. James Thomson, a pioneer in human pluripotent stem cell research at the University of Wisconsin-Madison.  CDI's facilities are located in Madison, Wisconsin. See www.cellulardynamics.com.


'/>"/>
SOURCE Cellular Dynamics International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Profiler at the cellular level
2. Cellular Dynamics Launches Innovative Research Grant Program
3. Permeon reveals discovery of Intraphilins as new approach to intracellular biologic drugs
4. Medical College of Wisconsin and Cellular Dynamics Awarded NHLBI Grant Using Human Induced Pluripotent Stem Cells
5. Arteriocyte and the U.S. Army Institute of Surgical Research (USAISR) Sign a CRADA to Speed Development of Cellular Therapies for Orthopaedic Trauma
6. Terumo Americas Holding, Inc., Agrees to Acquire Harvest Technologies Corporation, a Leader in the Development of Point-of-Care Cellular Therapy
7. Cellular Dynamics Licenses Technology From ViaCyte
8. Cellular Dynamics International Scientists Report on Efficient Method to Produce Footprint-Free Induced Pluripotent Stem Cells (iPSCs) Under Feeder-Free Conditions
9. Summer Street Research Partners Closes Financing for ImmunoCellular Therapeutics, Ltd.
10. Cellular Dynamics International to Present at 29th Annual JPMorgan Healthcare Conference
11. Intra-Cellular Therapies Announces Positive Results with ITI-002 in Pre-Clinical Models of Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... 2017 , ... PMG Research is pleased to announce its participation ... Conference Forum in Boston on April 3-4, 2017. The CTC conference focuses on how ... and bring them closer to the patient. Clinical Trial Collaborations also will present an ...
(Date:3/27/2017)... 27, 2017 Neurotrope, Inc. (OTCQB: NTRP),  ... neurodegenerative diseases, including Alzheimer,s disease, today announced that ... list the Company,s common stock on the NASDAQ ... Stock Market, a unit of the NASDAQ OMX ... the Opening Bell at the NASDAQ MarketSite in ...
(Date:3/24/2017)... Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: SVA), ... , today announced that its board of directors has amended its ... from March 27, 2017 to March 27, 2018. The amendment was not ... Biotech Ltd. ... Sinovac Biotech Ltd. is a China -based ...
(Date:3/23/2017)... Malden, MA (PRWEB) , ... March 23, 2017 ... ... as, “a viscoelastic material that exhibits both viscous and elastic characteristics when deformed, ... AxioMed disc polymer exhibits properties to gently absorb compressive forces and return to ...
Breaking Biology Technology:
(Date:2/21/2017)... N.Y. and PORTLAND, Ore. ... ) and the Avamere Family of Companies (Avamere Health ... today announced a six-month research study that will apply ... improve eldercare at senior living and health centers. By ... Avamere hopes to gain insights into physical and environmental ...
(Date:2/14/2017)... Feb. 14, 2017  Wake Forest Baptist Medical Center ... new chief executive officer (CEO). Freischlag joins the medical ... D. McConnell , M.D., who last year announced that ... Medical Center, after leading it since 2008.   ... of Wake Forest Baptist,s academic health system, which includes ...
(Date:2/10/2017)... Feb 10, 2017 Research and ... "Personalized Medicine - Scientific and Commercial Aspects" to ... ... Diagnosis is integrated with therapy for selection of treatment as ... detection and prevention of disease in modern medicine. Biochip/microarray technologies ...
Breaking Biology News(10 mins):